FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/04/024529 [Registered on: 08/04/2020] Trial Registered Prospectively
Last Modified On: 28/03/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Management of ankylosing spondylitis through Amavata treatment protocol- a pilot study 
Scientific Title of Study   To evaluate the combined effect of ruksha churna pinda sweda, virechana and yoga basti in the management of amavata w.s.r. to Ankylosing spondylitis - a pilot study (single arm open ended clinical study). 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Swarnakant Jena 
Designation  PG scholar 
Affiliation  All India Institute of Ayurveda 
Address  Academic block, department of panchakarma, All India Institute of Ayurveda, Sarita vihar

South West
DELHI
110076
India 
Phone  8766277160  
Fax    
Email  swarnakantjena@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Prasanth dharmarajan 
Designation  Assistance Professor 
Affiliation  All India Institute of Ayurveda 
Address  Academic block, 7th floor, All india institute of ayurveda, Sarita vihar, New delhi.

South West
DELHI
110076
India 
Phone    
Fax    
Email  drprasanthd@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Prasanth dharmarajan 
Designation  Assistance Professor 
Affiliation  All India Institute of Ayurveda 
Address  Academic block, 7th floor, All india institute of Ayurveda, Sarita vihar, new delhi

South West
DELHI
110076
India 
Phone    
Fax    
Email  drprasanthd@gmail.com  
 
Source of Monetary or Material Support  
All india institute of Ayurveda, Sarita Vihar, New delhi-110076 
 
Primary Sponsor  
Name  NIL 
Address  NIL 
Type of Sponsor  Other [] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Prasanth Dharmarajan  All india institute of Ayurveda  opd-6 Department of Panchakarma All India Institute of Ayurveda
South West
DELHI 
9895174060

drprasanthd@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M450||Ankylosing spondylitis of multiplesites in spine,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  not applicable  not applicable 
Intervention  Ruksha churna pinda sweda Snehapana Virechana Yoga basti Shamana medication  Ruksha churna pinda sweda with Kolakulathadi churna for 7days Snehapana with Shadpala ghrita for 3-7th day(untill samyak snigdha lakshana found) Virechana with Trivrit churna+Triphala kwatha+Nimbamrutadi eranda taila Samsarjan karma for 3-5days as per suddhi yoga Basti- Anuvasana with Saindhavadi taila+Satapushpa(on 1,3,5,8th day) Niruha basti with honey+saindhav+Guggulu tiktak ghrita+Saddharana kalka+Guduchi sadhit ksheer Shamana medicine with Trayodashanga Guggulu-2tab TDS with Gandharvahastadi kwatha-20ml TDS After food  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Diagnosed case of Ankylosing spondylitis 
 
ExclusionCriteria 
Details  1. Chronicity of more than 5 yrs.

2. Severely deformed joints.
3. Cardiac disease, pulmonary tuberculosis, severe lung disease, diabetes and pregnant women.

4. Patients unfit for Snehana, Svedana,
Virechana and Basti Karma.


 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Reduction in pain.  after rookshana(7th day), after virechana(21thday), after yoga basti(30th day), after internal medication(60th day), after rest periiod(90th day) 
 
Secondary Outcome  
Outcome  TimePoints 
Overall improvement in quality of life.  Assesment will be taken on first day before start panchakarma, after rukshana, after virechana along with samsarjan karma, after yoga basti, after samana medicine on 60days, after rest period on 90days.  
 
Target Sample Size   Total Sample Size="15"
Sample Size from India="15" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   01/05/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   outcomes will be published in peer reviewed journals for wider dissemination 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Ankylosing spondylitis is a chronic inflammatory disorder that primarily involves the sacroiliac joints and the axial skeleton. There is also a variable involvement of peripheral joints and articular structures. Musculoskeletal pain, stiffness. Ruksha churna pinda sweda, virechana and yoga basti followed by internal medicine as gandharvahastadi kwatha and Trayodashanga guggulu may be beneficial to manage pain in Ankylosing spondylitis. To reduce the other symptoms like stiffness, fatigue it al so may be seen helpful. This is the preliminary study to make an attempt by including 15 patients from OPD of All india institute of Ayurveda New delhi. Total no of trial days 90days. Assessment will be done by BASFI, BAS-G, BASDI, BASMI.

 
Close